These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 14576122)
1. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Reuter S; Buck A; Grebe O; Nüssle-Kügele K; Kern P; Manfras BJ Antimicrob Agents Chemother; 2003 Nov; 47(11):3586-91. PubMed ID: 14576122 [TBL] [Abstract][Full Text] [Related]
2. Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis. Jelicic K; Papic N; Viskovic K; Vince A Am J Trop Med Hyg; 2023 Mar; 108(3):581-583. PubMed ID: 36716742 [TBL] [Abstract][Full Text] [Related]
3. Effect of amphotericin B on larval growth of Echinococcus multilocularis. Reuter S; Merkle M; Brehm K; Kern P; Manfras B Antimicrob Agents Chemother; 2003 Feb; 47(2):620-5. PubMed ID: 12543669 [TBL] [Abstract][Full Text] [Related]
4. Disseminated hydatid disease in a child: albendazole treatment of orbital cyst. Papathanassiou M; Petrou P; Zampeli E; Vergados I; Paikos P Eur J Ophthalmol; 2008; 18(6):1034-6. PubMed ID: 18988186 [TBL] [Abstract][Full Text] [Related]
6. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583 [TBL] [Abstract][Full Text] [Related]
7. Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography. Zheng J; Wang J; Zhao J; Meng X Korean J Radiol; 2018; 19(1):40-46. PubMed ID: 29353998 [TBL] [Abstract][Full Text] [Related]
8. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Liu W; Delabrousse É; Blagosklonov O; Wang J; Zeng H; Jiang Y; Wang J; Qin Y; Vuitton DA; Wen H Parasite; 2014; 21():74. PubMed ID: 25531446 [TBL] [Abstract][Full Text] [Related]
10. Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology. Ammann RW; Stumpe KD; Grimm F; Deplazes P; Huber S; Bertogg K; Fischer DR; Müllhaupt B PLoS Negl Trop Dis; 2015; 9(9):e0003964. PubMed ID: 26389799 [TBL] [Abstract][Full Text] [Related]
11. Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis. Tappe D; Müller A; Frosch M; Stich A Ann Trop Med Parasitol; 2009 Mar; 103(2):177-81. PubMed ID: 19208302 [No Abstract] [Full Text] [Related]
12. Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazole. Gottstein B; Eckert J; Woodtli W Z Parasitenkd; 1984; 70(3):385-9. PubMed ID: 6741224 [TBL] [Abstract][Full Text] [Related]
13. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Reuter S; Schirrmeister H; Kratzer W; Dreweck C; Reske SN; Kern P Clin Infect Dis; 1999 Nov; 29(5):1157-63. PubMed ID: 10524957 [TBL] [Abstract][Full Text] [Related]
14. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. Caoduro C; Porot C; Vuitton DA; Bresson-Hadni S; Grenouillet F; Richou C; Boulahdour H; Blagosklonov O J Nucl Med; 2013 Mar; 54(3):358-63. PubMed ID: 23303963 [TBL] [Abstract][Full Text] [Related]
15. Proliferation and metastases formation of larval Echinococcus multilocularis. I. Animal model, macroscopical and histological findings. Eckert J; Thompson RC; Mehlhorn H Z Parasitenkd; 1983; 69(6):737-48. PubMed ID: 6659651 [TBL] [Abstract][Full Text] [Related]
16. Effect of plasma mebendazole concentrations in the treatment of human echinococcosis. Woodtli W; Bircher J; Witassek F; Eckert J; Wüthrich B; Ammann RW Am J Trop Med Hyg; 1985 Jul; 34(4):754-60. PubMed ID: 4025689 [TBL] [Abstract][Full Text] [Related]
17. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Swiss Echinococcosis Study Group. Ammann RW; Ilitsch N; Marincek B; Freiburghaus AU Hepatology; 1994 Mar; 19(3):735-42. PubMed ID: 8119701 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Reuter S; Grüner B; Buck AK; Blumstein N; Kern P; Reske SN Nuklearmedizin; 2008; 47(4):147-52. PubMed ID: 18690373 [TBL] [Abstract][Full Text] [Related]
19. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Bresson-Hadni S; Blagosklonov O; Knapp J; Grenouillet F; Sako Y; Delabrousse E; Brientini MP; Richou C; Minello A; Antonino AT; Gillet M; Ito A; Mantion GA; Vuitton DA Liver Transpl; 2011 Jul; 17(7):855-65. PubMed ID: 21455928 [TBL] [Abstract][Full Text] [Related]
20. Salvage Therapy for Alveolar Echinococcosis-A Case Series. Burkert S; Peters L; Bloehdorn J; Grüner B Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]